Adulteration of over-the-counter slimming products with pharmaceutical analogues - An emerging threat

Hong Kong Medical Journal

Volumn 13, Issue 3, 2007, Pages 216-220

  Yuen, Y P ^a   Lai, C K ^a   Poon, W T ^a   Ng, S W ^a   Chan, Albert Y W ^a   Mak, Tony W L ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Anti obesity agents; Fenfluramine; Liver failure, acute; Weight loss

Indexed keywords

ALOE EMODIN; ANTHRAQUINONE; ANTIOBESITY AGENT; CAFFEINE; CHLORPHENIRAMINE; CODEINE; DICLOFENAC; EMODIN; FENFLURAMINE; HYDROCHLOROTHIAZIDE; MAZINDOL; N NITROSOFENFLURAMINE; N NORSIBUTRAMINE; NICOTINAMIDE; NON PRESCRIPTION DRUG; PARACETAMOL; PHENOLPHTHALEIN; PHENTERMINE; PROPRANOLOL; SIBUTRAMINE; THYROID HORMONE; THYROXINE; TIRATRICOL; UNCLASSIFIED DRUG; VITAMIN;

ACUTE PSYCHOSIS; ADULT; AGE; AORTA VALVE REGURGITATION; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; FEMALE; HEART ARREST; HEART RIGHT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; THYROID FUNCTION TEST; WEAKNESS;

ADULT; ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; CHEMISTRY, PHARMACEUTICAL; CYCLOBUTANES; DRUG AND NARCOTIC CONTROL; DRUG CONTAMINATION; DRUGS, NON-PRESCRIPTION; FEMALE; FENFLURAMINE; HONG KONG; HOSPITALIZATION; HUMANS; LIVER; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; THYROID HORMONES; TOXICITY TESTS; WEIGHT LOSS;

EID: 34250318527     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-85.
2. Lai CK, Lee T, Au KM, Chan AY. Uniform solid-phase extraction procedure for toxicological drug screening in serum and urine by HPLC with photodiode-array detection. Clin Chem 1997;43:312-25.
3. Nakadai A, Inagaki H, Minami M, et al. Determination of the optical purity of N-nitrosofenfluramine found in the Chinese slimming diet [in Japanese]. Yakugaku Zasshi 2003;123:805-9.
4. Thevis M, Sigmund G, Schiffer AK, Schanzer W. Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry. Eur J Mass Spectrom (Chichester, Eng) 2006;12:129-36.
5. Yuen MF, Tam S, Fung J, Wong DK, Wong BC, Lai CL. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 2006;24:1179-86.
6. McMurray J, Bloomfield P, Miller HC. Irreversible pulmonary hypertension after treatment with fenfluramine. Br Med J (Clin Res Ed) 1986;292:239-40.
7. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:581-8.
8. Nisoli E, Carruba MO. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action. Obes Rev 2000;1:127-39.
9. Binkley K, Knowles SR. Sibutramine and panic attacks. Am J Psychiatry 2002;159:1793-4.
10. Cordeiro Q, Vallada H. Sibutramine-induced mania episode in a bipolar patient. Int J Neuropsychopharmacol 2002;5:283-4.
11. Taflinski T, Chojnacka J. Sibutramine-associated psychotic episode. Am J Psychiatry 2000;157:2057-8.
12. Vidal C, Quandte S. Identification of a sibutramine-metabolite in patient urine after intake of a "pure herbal" Chinese slimming product. Ther Drug Monit 2006;28:690-2.
13. Jung J, Hermanns-Clausen M, Weinmann W. Anorectic sibutramine detected in a Chinese herbal drug for weight loss. Forensic Sci Int 2006;161:221-2.
14. Lai V, Smith A, Thorburn D, Raman VS. Severe hepatic injury and adulterated Chinese medicines. BMJ 2006;332:304-5.
15. Lau G, Lo DS, Yao YJ, Leong HT, Chan CL, Chu SS. A fatal case of hepatic failure possibly induced by nitrosofenfluramine: a case report. Med Sci Law 2004;44:252-63.
16. Adachi M, Saito H, Kobayashi H, et al. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann Intern Med 2003;139:488-92.
17. Satoh K, Nonaka R, Tada Y, et al. Effects of N-nitrosofenfluramine, a component of Chinese dietary supplement for weight loss, on CD-1 mice. Arch Toxicol 2006;80:605-13.
18. Kawaguchi T, Harada M, Arimatsu H, et al. Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. J Gastroenterol Hepatol 2004;19:349-50.
19. Diggle GE. Thalidomide: 40 years on. Int J Clin Pract 2001;55:627-31.
20. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286:954-9.
21. Zou P, Oh SS, Kiang KH, Low MY, Bloodworth BC. Detection of sibutramine, its two metabolites and one analogue in a herbal product for weight loss by liquid chromatography triple quadrupole mass spectrometry and time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2007;21:614-8.
22. Unauthorised drugs. Ministry of Health, Labour and Welfare (Japan) website: http://www.mhlw.go.jp/kinkyu/diet/index.html. Accessed 21 Nov 2006.
23. Latest news on slimming products. Bureau of Drug and Food Analysis (Taiwan) website: http://www.nlfd.gov.tw/ShowModule.aspx?mtab=Doc&act= Detail&docid=3923&t ab=528. Accessed 21 Nov 2006.